Cerebras' (NASDAQ: CBRS) Q2 results provided a catalyst for sellers, initially sending shares down roughly 16% in extended trading following the report. The reality, however, is that this market’s near-term focus is disconnecting it from reality.
While one-offs, including non-cash impairment and share-based compensation, cut into profitability, and revenue growth was tepid relative to expectations, the fundamental story continues to strengthen.
